Skip to main content
OpenTrials
Completed

NCT Number: NCT00332943

MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil

The purpose of this study is to determine whether Barium or BariumFerumoxsil is better for fecal tagging in MR colonography. Patients referred to colonoscopy are offered MR colonography before colonoscopy. Two days before colonography, patients ingest either a contrast agent A (200 ml Barium sulphate solution 1g/ml)) four times a day or a 200 ml contrast agent B (Barium sulfate(25%) and Ferumoxil(75%)) four times a day, which will render fecal masses "invisible" on the following MR colonography. The patients are randomised to either contrast agent A or B. The examinations are evaluated by two independent blinded readers, who will rate the tagging quality of the contrast agents. The quality of tagging will be rated by a Visual Analog Scale (VAS) and Relative contrast (ReCon = Iwall - Ilumen/ Iwall + Ilumen).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Department of Radiology Copenhagen University Hospital Herlev

Copenhagen, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspicion of colorectal polyps or cancer
  • Referred for colonoscopy

Exclusion criteria

  • Suspicion of IBD
  • Pacemaker
  • Metal in the body
  • Claustrophobia
  • Pregnancy

Treatment and study plan

MR colonography with fecal tagging

Procedure

Primary outcomes

  1. Quality of fecal tagging agent

  2. Sensitivity of VAS score vs. ReCon score

Sponsors and collaborators

Lead sponsor

Herlev Hospital

Other

Collaborators

  • University Hospital, Gentofte, Copenhagen

Registry information

Important dates

Study start
2005
Study completion
2006
First posted
Jun 2, 2006
Registry last updated
Sep 20, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.